Related Experiment Video

Updated: Aug 17, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Mechanism and drug treatment of atherothrombosis]

Róbert Gábor Kiss1

  • 1Országos Gyógyintézeti Központ.

Orvosi Hetilap
|June 11, 2005
PubMed

Insights

Understanding atherothrombosis has advanced cardiovascular medicine, highlighting combined drug therapies. Effective strategies include lipid-lowering drugs and combined antiplatelet therapy for plaque rupture, alongside reperfusion techniques for occlusive events.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis Research
  • Pharmacology

Background:

  • Atherothrombosis understanding has fundamentally shifted cardiovascular medicine.
  • The complexity of atherothrombosis necessitates multifaceted treatment approaches.

Purpose of the Study:

  • To outline the importance of combined medical drug therapy in managing atherothrombosis.
  • To review current treatment options for acute atherothrombosis and its complications.

Main Methods:

  • Review of recent findings on atherothrombosis processes and consequences.
  • Analysis of the impact of selective cyclooxygenase-2 inhibitors and lipid-lowering drugs.
  • Evaluation of combined antiplatelet strategies and reperfusion techniques.

Main Results:

  • Selective cyclooxygenase-2 inhibitors show detrimental effects on vascular integrity.
  • Lipid-lowering drugs with pleiotropic effects are viable acute-phase treatments.
  • Combined antiplatelet therapy is effective for coronary artery plaque rupture, regardless of origin.

Conclusions:

  • Combined medical therapy is crucial for managing atherothrombosis.
  • Urgent reperfusion/revascularisation is essential for occlusive atherothrombosis.
  • Advances in understanding atherothrombosis guide modern cardiovascular treatment strategies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...